1ma7: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
<StructureSection load='1ma7' size='340' side='right' caption='[[1ma7]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='1ma7' size='340' side='right' caption='[[1ma7]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[1ma7]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[1ma7]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Bpp1 Bpp1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MA7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1MA7 FirstGlance]. <br> | ||
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1kbu|1kbu]], [[1crx|1crx]], [[3crx|3crx]], [[4crx|4crx]], [[1f44|1f44]]</td></tr> | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1kbu|1kbu]], [[1crx|1crx]], [[3crx|3crx]], [[4crx|4crx]], [[1f44|1f44]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ma7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ma7 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1ma7 RCSB], [http://www.ebi.ac.uk/pdbsum/1ma7 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ma7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ma7 OCA], [http://pdbe.org/1ma7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1ma7 RCSB], [http://www.ebi.ac.uk/pdbsum/1ma7 PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
Line 26: | Line 26: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 1ma7" style="background-color:#fffaf0;"></div> | |||
==See Also== | ==See Also== | ||
Line 33: | Line 34: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Bpp1]] | ||
[[Category: Baldwin, E P]] | [[Category: Baldwin, E P]] | ||
[[Category: Chu, V C]] | [[Category: Chu, V C]] |
Revision as of 19:38, 11 September 2015
Crystal structure of Cre site-specific recombinase complexed with a mutant DNA substrate, LoxP-A8/T27Crystal structure of Cre site-specific recombinase complexed with a mutant DNA substrate, LoxP-A8/T27
Structural highlights
Function[RECR_BPP1] Catalyzes site-specific recombination between two 34-base-pair LOXP sites. Its role is to maintain the phage genome as a monomeric unit-copy plasmid in the lysogenic state. Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedCre promotes recombination at the 34 bp LoxP sequence. Substitution of a critical C-G base pair in LoxP with an A-T base pair, to give LoxAT, reduced Cre binding in vitro and abolished recombination in vivo [Hartung, M., and Kisters-Woike, B. (1998) J. Biol. Chem. 273, 22884-22891].We demonstrated that LoxAT can be recombined in vitro. However, Cre discriminates against this substrate both before and after DNA binding. The preference for LoxP over LoxAT is the result of reduced binding and a slower turnover rate, amplified by changes in cooperativity of complex assembly. With LoxAT, similar levels of substrate turnover required 2-2.5-fold higher protein-DNA concentrations compared to LoxP, but the sigmoidal behavior of the concentration dependence was more pronounced. Further, the Cre-LoxAT complexes reacted 4-5-fold more slowly. In the 2.3 A resolution Cre-LoxAT complex structure, the major groove Arg259-guanine interaction was disrupted, explaining the reduced binding. Overall structural shifts and mobility changes indicate more favorable interactions between subunits, providing a hypothesis for the reduced turnover rate. Concomitant with the displacement of Arg259 from the DNA, adjacent charged residues Glu262 and Glu266 shifted to form salt bridges with the Arg259 guanidinium moiety. Substitution of Glu262 and Glu266 with glutamine increased Cre complex assembly efficiency and reaction rates with both LoxAT and LoxP, but diminished Cre's ability to distinguish them. The increased rate of this variant suggests that DNA substrate binding and turnover are coupled. The improved efficiency, made at some expense of sequence discrimination, may be useful for enhancing recombination in vivo. Modulation of the active complex assembly and turnover rate by protein-DNA interactions in Cre-LoxP recombination.,Martin SS, Chu VC, Baldwin E Biochemistry. 2003 Jun 10;42(22):6814-26. PMID:12779336[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|